Lingyi Wen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lingyi Wen has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
- Ying-Kun Guo
Department of Radiology, Key Laboratory of Obstetric & Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China
8 shared publications Zhongqin Zhou
Department of Radiology, Medical Imaging Center, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education; Development and Related Diseases of Women and Children Key Laboratory of Sichuan Province; Children's Medicine Key Laboratory of Sichuan Province, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China
8 shared publicationsLei Hu
Department of Radiology, Medical Imaging Center, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education; Development and Related Diseases of Women and Children Key Laboratory of Sichuan Province; Children's Medicine Key Laboratory of Sichuan Province, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China
7 shared publicationsShiganmo Azhe
Department of Radiology, Medical Imaging Center, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education; Development and Related Diseases of Women and Children Key Laboratory of Sichuan Province; Children's Medicine Key Laboratory of Sichuan Province, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China
7 shared publicationsChuan Wang
5 shared publicationsKaiyu Zhou
5 shared publications
Latest Publications
- 12 October 2026
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- p. 1-15
Coronary artery imaging in Kawasaki disease: recent updates in imaging techniques and clinical indications
Coronary artery involvement in Kawasaki disease should be evaluated throughout all disease stages. Generally, multimodality imaging is necessary for both the acute and chronic phases of coronary artery abnormalities. This review summarizes current clinical indications and recent technical advances in coronary artery imaging in Kawasaki disease with an emphasis on the roles of computed tomography and magnetic resonance imaging. Echocardiography remains the first-line modality in all disease stages for evaluating coronary artery lesions and ventricular function. Recent technical developments in coronary computed tomography angiography can provide the accurate diagnosis of coronary artery lesions including stenosis and thrombus at substantially reduced radiation dose, supporting its selective use in serial follow-up. Cardiac magnetic resonance imaging offers the comprehensive evaluation of inducible myocardial ischemia, ventricular function, inflammation, and fibrosis. Invasive catheter angiography is reserved for complex or interventional cases. This review also addresses technical considerations and potential pitfalls for each imaging modality. Continued technical developments and their optimization with standardized imaging protocols and reports are expected to enhance diagnostic precision and eventually improve clinical outcomes in children with Kawasaki disease.
- 12 October 2026
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- p. 1-15
Coronary artery imaging in Kawasaki disease: recent updates in imaging techniques and clinical indications
Coronary artery involvement in Kawasaki disease should be evaluated throughout all disease stages. Generally, multimodality imaging is necessary for both the acute and chronic phases of coronary artery abnormalities. This review summarizes current clinical indications and recent technical advances in coronary artery imaging in Kawasaki disease with an emphasis on the roles of computed tomography and magnetic resonance imaging. Echocardiography remains the first-line modality in all disease stages for evaluating coronary artery lesions and ventricular function. Recent technical developments in coronary computed tomography angiography can provide the accurate diagnosis of coronary artery lesions including stenosis and thrombus at substantially reduced radiation dose, supporting its selective use in serial follow-up. Cardiac magnetic resonance imaging offers the comprehensive evaluation of inducible myocardial ischemia, ventricular function, inflammation, and fibrosis. Invasive catheter angiography is reserved for complex or interventional cases. This review also addresses technical considerations and potential pitfalls for each imaging modality. Continued technical developments and their optimization with standardized imaging protocols and reports are expected to enhance diagnostic precision and eventually improve clinical outcomes in children with Kawasaki disease.
- Open Access
- 9 June 2026
- Published by Elsevier in SSRN Electronic Journal
Deep Learning-Based Automatic Plaque Analysis from Coronary Computed Tomography Angiography for Predicting Outcomes: A Systematic Review and Meta-Analysis
Background: Coronary computed tomography angiography (CCTA)-based plaque characteristics predict cardiovascular events, but the prognostic value of deep learning (DL)-based automated plaque analysis remains uncertain. Herein, we conduct a meta-analysis to assess the predictive value of DL-based automatic plaque analysis of CCTA for composite clinical outcomes.Methods: A comprehensive literature search was conducted in PubMed, Embase, Web of Science, and the Cochrane Library to identify original articles published up to May 1, 2026. Eligible studies assessed DL-based total plaque volume (TPV), luminal stenosis severity, or high-risk plaque (HRP) for clinical outcomes. Primary outcomes were defined as fatal or non-fatal myocardial infarction (MI), nonfatal stroke, coronary revascularization, hospitalization for unstable angina, recurrence of cardiac symptoms and all-cause mortality. Risk of bias was assessed with Quality In Prognosis Studies (QUIPS) tool. The protocol was registered with PROSPERO (CRD42024627668).Findings: Eleven studies including 28,904 participants (mean age 62.4 years; 18,158 [62.8%] male) with 1.0 to 10.3 years of follow-up were included. For the composite clinical outcomes, DL-based luminal stenosis severity (HR 4.73, 95% CI 1.89-11.85, P=0.0009; unadjusted HR 5.26, 95% CI 2.42-11.44, P<0.0001), TPV (HR 1.78, 95% CI 1.44-2.19, P<0.00001; unadjusted HR 2.18, 95% CI 1.35-3.52, P=0.001), and HRP (HR 1.37, 95% CI 1.02-1.84, P=0.04; unadjusted HR 1.66, 95% CI 1.24-2.22, P=0.0007) were significantly associated with outcomes. In analyses restricted to cardiovascular death or MI, DL-based TPV remained the strongest predictor (HR 2.06, 95% CI 1.13-3.75, P=0.02; unadjusted HR 2.79, 95% CI 1.22-6.40, P=0.02), whereas the association between HRP and outcomes was significant only in univariable analysis (unadjusted HR 1.66, 95% CI 1.17-2.34, P=0.004) and was attenuated after multivariable adjustment (HR 1.50, 95% CI 0.98-2.30, P=0.06). Interpretation: DL–based automated CCTA plaque analysis provides prognostic information, including TPV, luminal stenosis severity, and HRP, supporting its use for coronary risk stratification.
- 9 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessDeep Learning-Based Automatic Plaque Analysis from Coronary Computed Tomography Angiography for Predicting Outcomes: A Systematic Review and Meta-Analysis
Background: Coronary computed tomography angiography (CCTA)-based plaque characteristics predict cardiovascular events, but the prognostic value of deep learning (DL)-based automated plaque analysis remains uncertain. Herein, we conduct a meta-analysis to assess the predictive value of DL-based automatic plaque analysis of CCTA for composite clinical outcomes.Methods: A comprehensive literature search was conducted in PubMed, Embase, Web of Science, and the Cochrane Library to identify original articles published up to May 1, 2026. Eligible studies assessed DL-based total plaque volume (TPV), luminal stenosis severity, or high-risk plaque (HRP) for clinical outcomes. Primary outcomes were defined as fatal or non-fatal myocardial infarction (MI), nonfatal stroke, coronary revascularization, hospitalization for unstable angina, recurrence of cardiac symptoms and all-cause mortality. Risk of bias was assessed with Quality In Prognosis Studies (QUIPS) tool. The protocol was registered with PROSPERO (CRD42024627668).Findings: Eleven studies including 28,904 participants (mean age 62.4 years; 18,158 [62.8%] male) with 1.0 to 10.3 years of follow-up were included. For the composite clinical outcomes, DL-based luminal stenosis severity (HR 4.73, 95% CI 1.89-11.85, P=0.0009; unadjusted HR 5.26, 95% CI 2.42-11.44, P<0.0001), TPV (HR 1.78, 95% CI 1.44-2.19, P<0.00001; unadjusted HR 2.18, 95% CI 1.35-3.52, P=0.001), and HRP (HR 1.37, 95% CI 1.02-1.84, P=0.04; unadjusted HR 1.66, 95% CI 1.24-2.22, P=0.0007) were significantly associated with outcomes. In analyses restricted to cardiovascular death or MI, DL-based TPV remained the strongest predictor (HR 2.06, 95% CI 1.13-3.75, P=0.02; unadjusted HR 2.79, 95% CI 1.22-6.40, P=0.02), whereas the association between HRP and outcomes was significant only in univariable analysis (unadjusted HR 1.66, 95% CI 1.17-2.34, P=0.004) and was attenuated after multivariable adjustment (HR 1.50, 95% CI 0.98-2.30, P=0.06). Interpretation: DL–based automated CCTA plaque analysis provides prognostic information, including TPV, luminal stenosis severity, and HRP, supporting its use for coronary risk stratification.
- Open Access
- 1 January 2026
- Published by XMLink in Cardiovascular Imaging Asia
- Vol. 10 (3) , 45-59
The ASCI Registry: Rationale, Design, and Roadmap With an Asian Multi-Center Cloud Platform
Hwang SH, et al. Cardiovasc Imaging Asia. 2026 Jul;10(3):45-59. https://doi.org/10.22468/cvia.2026.00052
- 1 January 2026
- Published by XMLink in Cardiovascular Imaging Asia
- Vol. 10 (3) , 45-59
Open AccessThe ASCI Registry: Rationale, Design, and Roadmap With an Asian Multi-Center Cloud Platform
Hwang SH, et al. Cardiovasc Imaging Asia. 2026 Jul;10(3):45-59. https://doi.org/10.22468/cvia.2026.00052
- 1 December 2025
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 7 (6) , e250444
Top 2025 Images in Cardiothoracic Imaging
- 1 December 2025
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 7 (6) , e250444
Top 2025 Images in Cardiothoracic Imaging
- Open Access
Clinical impact of multimodal cardiac imaging in Kawasaki disease: a prospective Kawasaki disease cardiac imaging (KDCI) cohort study with follow-up data in a Chinese population
Purpose: Coronary artery involvement remains the primary focus in the long-term management of Kawasaki disease (KD). However, previous studies suggest that myocardial abnormalities frequently persist beyond coronary artery involvement in KD patients. Yet, their temporal evolution and clinical implications remain poorly characterised. To address this gap, we established the Kawasaki disease cardiac imaging (KDCI) cohort, integrating cardiac magnetic resonance (CMR) with echocardiography, coronary CT angiography (CCTA) and invasive angiography. These multimodal imaging approaches enable comprehensive assessment of cardiac abnormalities and elucidate the role of cardiac imaging in optimising long-term KD management. Participants: The KDCI cohort is a prospective study aiming to enrol 400–500 KD patients diagnosed at West China Second University Hospital from September 2018 to September 2035. To date, 207 participants have been recruited. Participants will perform the multimodal cardiac imaging including echocardiography, CMR, CCTA, invasive angiography and comprehensive laboratory testing under a scheduled protocol in the follow-up. Findings to date: The KDCI cohort has established baseline characteristics for 207 KD patients. Of those included to date, 72.0% (149/207) received intravenous immunoglobulin (IVIG) treatment, with 26.1% (54/207) demonstrating IVIG resistance, and 37.7% (78/207) exhibiting coronary artery dilatation. Longitudinal follow-up data are available for 80.7% (167/207) of participants, with a median follow-up duration of 2.7 years and a follow-up patient-years of 594 patient-years. Of the 207 patients, 16.9% (35/207) patients experienced endpoint events, encompassing coronary artery thrombosis (8.2%, 17/207), coronary stenosis/obstruction (5.3% 11/207) and clinical myocardial infarction (1.9%, 4/207). Based on the data collected, we have demonstrated the cardiac abnormalities beyond coronary artery involvement in KD by CMR and CCTA. Future plan: The KDCI cohort will maintain ongoing recruitment and longitudinal follow-up, with a projected enrolment exceeding 400 participants by 2035. This expansion will yield a median follow-up duration of 10 years, providing robust long-term outcome data. We have implemented standardised protocols for scheduled follow-up assessments and data collection in newly enrolled patients. Furthermore, planned genomic analyses will be incorporated to investigate the molecular pathogenesis and prognostic determinants of KD.
Open AccessClinical impact of multimodal cardiac imaging in Kawasaki disease: a prospective Kawasaki disease cardiac imaging (KDCI) cohort study with follow-up data in a Chinese population
Purpose: Coronary artery involvement remains the primary focus in the long-term management of Kawasaki disease (KD). However, previous studies suggest that myocardial abnormalities frequently persist beyond coronary artery involvement in KD patients. Yet, their temporal evolution and clinical implications remain poorly characterised. To address this gap, we established the Kawasaki disease cardiac imaging (KDCI) cohort, integrating cardiac magnetic resonance (CMR) with echocardiography, coronary CT angiography (CCTA) and invasive angiography. These multimodal imaging approaches enable comprehensive assessment of cardiac abnormalities and elucidate the role of cardiac imaging in optimising long-term KD management. Participants: The KDCI cohort is a prospective study aiming to enrol 400–500 KD patients diagnosed at West China Second University Hospital from September 2018 to September 2035. To date, 207 participants have been recruited. Participants will perform the multimodal cardiac imaging including echocardiography, CMR, CCTA, invasive angiography and comprehensive laboratory testing under a scheduled protocol in the follow-up. Findings to date: The KDCI cohort has established baseline characteristics for 207 KD patients. Of those included to date, 72.0% (149/207) received intravenous immunoglobulin (IVIG) treatment, with 26.1% (54/207) demonstrating IVIG resistance, and 37.7% (78/207) exhibiting coronary artery dilatation. Longitudinal follow-up data are available for 80.7% (167/207) of participants, with a median follow-up duration of 2.7 years and a follow-up patient-years of 594 patient-years. Of the 207 patients, 16.9% (35/207) patients experienced endpoint events, encompassing coronary artery thrombosis (8.2%, 17/207), coronary stenosis/obstruction (5.3% 11/207) and clinical myocardial infarction (1.9%, 4/207). Based on the data collected, we have demonstrated the cardiac abnormalities beyond coronary artery involvement in KD by CMR and CCTA. Future plan: The KDCI cohort will maintain ongoing recruitment and longitudinal follow-up, with a projected enrolment exceeding 400 participants by 2035. This expansion will yield a median follow-up duration of 10 years, providing robust long-term outcome data. We have implemented standardised protocols for scheduled follow-up assessments and data collection in newly enrolled patients. Furthermore, planned genomic analyses will be incorporated to investigate the molecular pathogenesis and prognostic determinants of KD.
- Open Access
- 1 September 2025
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 15 (9) , 8348-8358
Comprehensive assessment of patients with Kawasaki disease without coronary artery aneurysm
Background: In the current guidelines, the management algorithm for patients with Kawasaki disease (KD) without coronary artery (CA) aneurysms primarily depends on the clinical experience of pediatricians. It is necessary to conduct a comprehensive evaluation of these patients to provide a higher level of evidence for their management. Therefore, our study aimed to assess patients with KD using multidimensional data and investigate their prognosis. Methods: A total of 455 patients with KD were retrospectively recruited and divided into a non-CA involvement group (n=313) and a CA dilation-only group (n=142), with 16.1% (50/311) and 15.5% (22/142), respectively, undergoing cardiac magnetic resonance (CMR) examinations during recovery. Data regarding inflammatory markers, electrocardiography, and echocardiography were compared between the two groups both in the acute phase and during the recovery period. Kaplan-Meier analysis was performed to estimate the cumulative probability of the endpoints including coronary events, cardiac death, heart failure, and new-onset malignant arrhythmias. Results: Baseline inflammatory markers, including white blood cell count (WBC) and C-reactive protein (CRP), were not significantly different between patients with KD and non-CA involvement and those with dilation only (median WBC: 14.1×109/L vs. 13.9×109/L, P=0.57; median CRP: 87.4 vs. 85.6 mg/L, P=0.73). In terms of echocardiography assessment at baseline, there were no significant differences between the non-CA involvement group and the dilation-only group in terms of left ventricular ejection fraction (67.8%±13.6% vs. 68.1%±10.3%; P=0.13) or fractional shortening (37.6%±5.3% vs. 35.4%±6.6%; P=0.25). For CMR assessment at recovery, the myocardial systolic function of patients with KD but non-CA involvement was not significantly different from that of patients with CA dilation only in terms of global radial strain (38.3%±18.7% vs. 39.9%±20.5%; P=0.20), global circumferential strain (–18.7%±6.8% vs. –18.3%±7.2%; P=0.38), and global longitudinal strain (–13.2%±3.7% vs. −13.4%±4.1%; P=0.17). The global native T1 value of patients with non-CA involvement was 1,296.5±74.1 msec, while that of patients with CA dilation only was 1,313.3±80.5 msec (P=0.21); there was also no significant difference in global T2 values between the two groups of patients (38.2±4.1 vs. 38.1±3.5 msec; P=0.53). Finally, at a median follow-up of 4.2 years, there was a favorable prognosis in both two groups of patients, with no patients reaching the endpoints. Conclusions: Comprehensive assessment revealed no significant differences between patients with KD and CA dilation only and those with non-CA involvement, and thus these patients should be treated according to the same medium-long-term management algorithm.
- 1 September 2025
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 15 (9) , 8348-8358
Open AccessComprehensive assessment of patients with Kawasaki disease without coronary artery aneurysm
Background: In the current guidelines, the management algorithm for patients with Kawasaki disease (KD) without coronary artery (CA) aneurysms primarily depends on the clinical experience of pediatricians. It is necessary to conduct a comprehensive evaluation of these patients to provide a higher level of evidence for their management. Therefore, our study aimed to assess patients with KD using multidimensional data and investigate their prognosis. Methods: A total of 455 patients with KD were retrospectively recruited and divided into a non-CA involvement group (n=313) and a CA dilation-only group (n=142), with 16.1% (50/311) and 15.5% (22/142), respectively, undergoing cardiac magnetic resonance (CMR) examinations during recovery. Data regarding inflammatory markers, electrocardiography, and echocardiography were compared between the two groups both in the acute phase and during the recovery period. Kaplan-Meier analysis was performed to estimate the cumulative probability of the endpoints including coronary events, cardiac death, heart failure, and new-onset malignant arrhythmias. Results: Baseline inflammatory markers, including white blood cell count (WBC) and C-reactive protein (CRP), were not significantly different between patients with KD and non-CA involvement and those with dilation only (median WBC: 14.1×109/L vs. 13.9×109/L, P=0.57; median CRP: 87.4 vs. 85.6 mg/L, P=0.73). In terms of echocardiography assessment at baseline, there were no significant differences between the non-CA involvement group and the dilation-only group in terms of left ventricular ejection fraction (67.8%±13.6% vs. 68.1%±10.3%; P=0.13) or fractional shortening (37.6%±5.3% vs. 35.4%±6.6%; P=0.25). For CMR assessment at recovery, the myocardial systolic function of patients with KD but non-CA involvement was not significantly different from that of patients with CA dilation only in terms of global radial strain (38.3%±18.7% vs. 39.9%±20.5%; P=0.20), global circumferential strain (–18.7%±6.8% vs. –18.3%±7.2%; P=0.38), and global longitudinal strain (–13.2%±3.7% vs. −13.4%±4.1%; P=0.17). The global native T1 value of patients with non-CA involvement was 1,296.5±74.1 msec, while that of patients with CA dilation only was 1,313.3±80.5 msec (P=0.21); there was also no significant difference in global T2 values between the two groups of patients (38.2±4.1 vs. 38.1±3.5 msec; P=0.53). Finally, at a median follow-up of 4.2 years, there was a favorable prognosis in both two groups of patients, with no patients reaching the endpoints. Conclusions: Comprehensive assessment revealed no significant differences between patients with KD and CA dilation only and those with non-CA involvement, and thus these patients should be treated according to the same medium-long-term management algorithm.
- Open Access
- 1 August 2025
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 15 (8) , 6627-6643
Potential predictive value of myocardial strain and strain rate for late gadolinium enhancement in children with a history of Kawasaki disease
Background: Kawasaki disease (KD) is an acute pediatric vasculitis with significant implications for coronary arteries and myocardium, potentially leading to long-term myocardial fibrosis. With the advancements in speckle tracking echocardiography (STE), ultrasound parameters have been shown to be reliable in the early detection of structural and functional myocardial abnormalities, thus mitigating some limitations of cardiac magnetic resonance imaging (MRI). Despite its gold standard status for assessing myocardial fibrosis, the application of cardiac magnetic resonance (CMR) with late gadolinium enhancement (LGE) in pediatrics is restricted. Therefore, this study aimed to investigate the correlation between myocardial strain parameters and LGE in children with KD. Methods: We prospectively recruited 100 children with KD and 25 healthy control (HC) children. Left ventricular (LV) function and LGE in the children were evaluated concurrently using echocardiography and CMR. Results: Of the 55 KD children (11 LGE-positive, 44 LGE-negative) and 22 HCs, LGE positivity was higher among those with giant coronary aneurysms (GCAs) and medium coronary aneurysms (MCAs). LGE-positive patients exhibited significantly reduced LV global longitudinal strain (GLS) and strain rates, including 4-chamber GLS [mid-myocardial layer (Mid): 16.82%±5.50% vs. 20.45%±2.43%, subepicardial myocardial layer (Subepi): 14.71%±4.76% vs. 17.67%±2.18%, subendocardial myocardial layer (Subendo): 19.33%±6.49% vs. 23.74%±2.84%] and 4-chamber early diastolic strain rate (SRe: 1.92±0.73 vs. 2.33±0.46 s–1), compared to LGE-negative patients and HCs. Conclusions: In the chronic phase, patients with KD may be at risk of myocardial fibrosis, underscoring the importance of evaluating myocardial function and LGE. Our study indicates that STE could be a valuable tool for assessing focal fibrosis in children with chronic-phase KD. However, due to limitations such as a small sample size, high dropout rate of CMR, and differences in LGE distribution, future studies with larger sample sizes are needed to validate these findings and their predictive efficacy.
- 1 August 2025
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 15 (8) , 6627-6643
Open AccessPotential predictive value of myocardial strain and strain rate for late gadolinium enhancement in children with a history of Kawasaki disease
Background: Kawasaki disease (KD) is an acute pediatric vasculitis with significant implications for coronary arteries and myocardium, potentially leading to long-term myocardial fibrosis. With the advancements in speckle tracking echocardiography (STE), ultrasound parameters have been shown to be reliable in the early detection of structural and functional myocardial abnormalities, thus mitigating some limitations of cardiac magnetic resonance imaging (MRI). Despite its gold standard status for assessing myocardial fibrosis, the application of cardiac magnetic resonance (CMR) with late gadolinium enhancement (LGE) in pediatrics is restricted. Therefore, this study aimed to investigate the correlation between myocardial strain parameters and LGE in children with KD. Methods: We prospectively recruited 100 children with KD and 25 healthy control (HC) children. Left ventricular (LV) function and LGE in the children were evaluated concurrently using echocardiography and CMR. Results: Of the 55 KD children (11 LGE-positive, 44 LGE-negative) and 22 HCs, LGE positivity was higher among those with giant coronary aneurysms (GCAs) and medium coronary aneurysms (MCAs). LGE-positive patients exhibited significantly reduced LV global longitudinal strain (GLS) and strain rates, including 4-chamber GLS [mid-myocardial layer (Mid): 16.82%±5.50% vs. 20.45%±2.43%, subepicardial myocardial layer (Subepi): 14.71%±4.76% vs. 17.67%±2.18%, subendocardial myocardial layer (Subendo): 19.33%±6.49% vs. 23.74%±2.84%] and 4-chamber early diastolic strain rate (SRe: 1.92±0.73 vs. 2.33±0.46 s–1), compared to LGE-negative patients and HCs. Conclusions: In the chronic phase, patients with KD may be at risk of myocardial fibrosis, underscoring the importance of evaluating myocardial function and LGE. Our study indicates that STE could be a valuable tool for assessing focal fibrosis in children with chronic-phase KD. However, due to limitations such as a small sample size, high dropout rate of CMR, and differences in LGE distribution, future studies with larger sample sizes are needed to validate these findings and their predictive efficacy.
- 18 June 2025
- Published by Springer Nature in Pediatric Radiology
- Vol. 55 (11) , 2459-2467
Association between left ventricular subclinical dysfunction and myocardial abnormalities in Kawasaki disease patients without coronary artery dilation
Background Previous studies have found that subclinical dysfunction was associated with coronary artery dilation in patients with Kawasaki disease. However, cardiac function and myocardial tissue characteristics have rarely been studied in Kawasaki disease patients without coronary artery dilation. Objective Our study aims to evaluate cardiac dysfunction and myocardial tissue characteristics in Kawasaki disease patients without coronary artery dilation using cardiac magnetic resonance imaging (MRI) and then investigate the association between subclinical dysfunction and myocardial abnormalities. Materials and methods Seventy-two (48 males, average age 6.2 ± 4.5 years) Kawasaki disease patients without coronary artery dilation and 30 control patients (20 males, average age 6.8 ± 3.3 years) were retrospectively enrolled in this study. Strain parameters and mapping values were compared between Kawasaki disease patients and control patients. Results The left ventricular ejection fraction (LVEF) of Kawasaki disease patients is in the normal range. However, the global longitudinal strain of patients is lower than that of control patients (-13.2 ± 3.9 vs. -15.1 ± 4.2%, P = 0.03). The global native T1 value of Kawasaki disease patients is higher than that of control patients (1,306.5 ± 75.2 vs. 1,264.3 ± 65.5 ms, P = 0.04). Pearson’s analysis shows that the global native T1 value is correlated with global longitudinal strain (r = 0.22, P < 0.01) in Kawasaki disease patients. Further multiple linear regression analysis finds the global T1 value is independently associated with global longitudinal strain (β = 0.11, P = 0.01) after adjusting for age and sex. Conclusion Kawasaki disease patients without coronary artery dilation suffer subclinical dysfunction, which may be associated with myocardial abnormalities during the chronic phase. Graphical Abstract
- 18 June 2025
- Published by Springer Nature in Pediatric Radiology
- Vol. 55 (11) , 2459-2467
Association between left ventricular subclinical dysfunction and myocardial abnormalities in Kawasaki disease patients without coronary artery dilation
Background Previous studies have found that subclinical dysfunction was associated with coronary artery dilation in patients with Kawasaki disease. However, cardiac function and myocardial tissue characteristics have rarely been studied in Kawasaki disease patients without coronary artery dilation. Objective Our study aims to evaluate cardiac dysfunction and myocardial tissue characteristics in Kawasaki disease patients without coronary artery dilation using cardiac magnetic resonance imaging (MRI) and then investigate the association between subclinical dysfunction and myocardial abnormalities. Materials and methods Seventy-two (48 males, average age 6.2 ± 4.5 years) Kawasaki disease patients without coronary artery dilation and 30 control patients (20 males, average age 6.8 ± 3.3 years) were retrospectively enrolled in this study. Strain parameters and mapping values were compared between Kawasaki disease patients and control patients. Results The left ventricular ejection fraction (LVEF) of Kawasaki disease patients is in the normal range. However, the global longitudinal strain of patients is lower than that of control patients (-13.2 ± 3.9 vs. -15.1 ± 4.2%, P = 0.03). The global native T1 value of Kawasaki disease patients is higher than that of control patients (1,306.5 ± 75.2 vs. 1,264.3 ± 65.5 ms, P = 0.04). Pearson’s analysis shows that the global native T1 value is correlated with global longitudinal strain (r = 0.22, P < 0.01) in Kawasaki disease patients. Further multiple linear regression analysis finds the global T1 value is independently associated with global longitudinal strain (β = 0.11, P = 0.01) after adjusting for age and sex. Conclusion Kawasaki disease patients without coronary artery dilation suffer subclinical dysfunction, which may be associated with myocardial abnormalities during the chronic phase. Graphical Abstract
- 1 June 2025
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 7 (3) , e240303
Pericoronary Adipose Tissue CT Attenuation in Kawasaki Disease and Association with Coronary Artery Aneurysms, Myocardial Perfusion, and Coronary Events
Pericoronary adipose tissue CT attenuation used to quantify coronary inflammation in patients with Kawasaki disease was associated with coronary artery aneurysm and myocardial perfusion and independently predicted occurrence of coronary events.
- 1 June 2025
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 7 (3) , e240303
Pericoronary Adipose Tissue CT Attenuation in Kawasaki Disease and Association with Coronary Artery Aneurysms, Myocardial Perfusion, and Coronary Events
Pericoronary adipose tissue CT attenuation used to quantify coronary inflammation in patients with Kawasaki disease was associated with coronary artery aneurysm and myocardial perfusion and independently predicted occurrence of coronary events.